Gene Therapy Setback: REGENXBIO’s RGX-121 Faces Regulatory Hurdles in Ultra-Rare Disease Treatment
Serina Therapeutics Begins First-in-Patient Dosing in Phase 1b Trial of SER‑252 for Advanced Parkinson’s Disease
New Gene Editing Program Aims to Address Root Cause of PKU
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Two Intellia Clinical Trials Released by the FDA bit.ly/4rOa6oh Read now at PatientWorthy.com
#PatientWorthy #Attr #amyloidosis #FDAapproval
This is TODAY- March 11th from @TripleNegativeBreastCancerFoundationJoin us March 11 at 1:00 PM ET for a ctDNA Testing Zoom Workshop with Dr. Dan Stover of Ohio State University Comprehensive Cancer Center. 🧬
Learn what circulating tumor DNA (ctDNA) is, how testing is used today, and what’s ahead. Stay for a live Q&A and gain valuable insights into the future of cancer care. Save your spot and register via the link!
#TNBCAwarenessMonth #CancerResearch #ctDNA
